Share
7,139 Posts.
lightbulb Created with Sketch. 572
clock Created with Sketch. 05/10/21
08:29
Share
Originally posted by silvahman:
↑
So true. At current share price everyone who has bought into MDC is now in the red despite all the success on their cannabis trials. How on earth MXC is worth 3x more than MDC is unbelievable. MDC has delivered in everything they have set out (successful trials) and should be on the end stretch for something big IMO. Don't see why MDC is so vulnerable compared to the rest. But perhaps there is something bigger at play here, like most stocks go through before take off. For a company on home stretch of successful cannabis pain drug it is valued incredibly cheap. 49millionaus$, only 35millionUS$, or 26millionGBP$.... for a company heavy in cannabis pain trials since 2015.... this is bonkers cheap.MXC is up 600% since IPO and has delivered nothing and not even at phase2 of their cannabis product.MDC is down 30% since IPO and is gearing up to Phase3 of a successful cancer pain cannabis trial. Technically MDC should be up 600% too from IPO =$1.20
Expand
imo they have delivered as much and more than most asx cannabis plays . my investment is for the patent on the gut pills and the novel delivery tech . the weed should be giving us freaking so many bananas though.
(20min delay)